ALLIANCE A041202 - Study Design | IMBRUVICA® (ibrutinib) HCP
Ibrutinib and Rituximab (IR) is Superior to Chemo-immunotherapy (CIT) in CLL: Big News, or is it really? And did they get it right? - CLL Society
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial - The Lancet Oncology
Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on - Molica - 2020 - Hematological Oncology - Wiley Online Library
Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials - ScienceDirect
IVO vs IO Phase 3 Trial of the Impact of Adding Venetoclax to Ibrutinib and Obinutuzumab in CLL
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study | Leukemia
Targeted therapy for the most common leukemia | MD Anderson Cancer Center
Cancers | Free Full-Text | Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial | Haematologica
Updates from the American Society of Hematology 2019 annual meeting: practice-changing studies in treatment-naïve chronic lymphocytic leukemia. - Abstract - Europe PMC
Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
Managing CLL With BTK Inhibitors - ppt download
Cancer and Leukemia Group B (CALGB)/Alliance 90203 trial (NCT00430183)... | Download Scientific Diagram
Current Perspectives on Therapy for Chronic Lymphocytic Leukemia | American Society of Clinical Oncology Educational Book
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia -
Reaping the Rewards of Innovative Care in CLL: From Targeted Strategies to Cellular Therapy
Ongoing or planned phase 3 trials in the first-line setting for CLL | Download Table
Alliance for Clinical Trials in Oncology on X: "Matthew Wieduwilt, MD, PhD @UCSDHealth leads @ALLIANCE_org A041703, an #immunotherapy trial for treating patients with acute lymphoblastic #leukemia that's newly diagnosed, has come back,
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia | Trials | Full Text
Clinical Trials – New Developments in Lymphoma
Managing CLL With BTK Inhibitors - ppt download
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study | Leukemia
